Skip to Primary Navigation

Skip to main content

PMCPA rules AstraZeneca UK responsible for employee’s social media activity

A photo of AstraZeneca's headquarters in Cambridge, UK.
Photo: Anthony Devlin/Getty Images for AstraZeneca

Kevin Kinsella

3 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

An employee clicking “like” on a third-party LinkedIn post was found to be a breach of seven clauses of the ABPI Code.

An employee’s itchy social media trigger finger has been ruled to put AstraZeneca UK Limited (AZ) in breach of multiple clauses of a pharma industry code of practice.

The UK’s Prescription Medicines Code of Practice Authority (PMCPA) issued its final resolution in a 2025 case related to when an

The

, , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience